Last reviewed · How we verify
Rhinovirus A-16 Infection
Imperial College London is conducting a rhinovirus challenge study to investigate exacerbations and immune responses in bronchiectasis patients. The study aims to recruit 54 participants and could provide valuable insights into the pathophysiology and potential therapeutic targets for this condition.
At a glance
| Generic name | Rhinovirus A-16 Infection |
|---|---|
| Sponsor | Imperial College London |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rhinovirus A-16 Infection CI brief — competitive landscape report
- Rhinovirus A-16 Infection updates RSS · CI watch RSS
- Imperial College London portfolio CI